Graf Akcie CARA (Cara Therapeutics Inc). Diskuze k akciím CARA. Aktuální informace CARA.

Základní informace o společnosti Cara Therapeutics Inc (Akcie CARA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 667.05M
Hodnota podniku (EV) 626.23M
Tržby 123.29M
EBITDA 6.864M
Zisk 8.354M
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 51.31
Forward P/E -0.39
EV/Sales 5.08
EV/EBITDA 91.23
EV/EBIT 78.60
PEG N/A
Price/Sales 5.41
P/FCF 43.53
Price/Book 2.68
Účetní hodnota na akcii 4.98
Hotovost na akcii 3.63
FCF vůči ceně 2.32 %
Počet zaměstnanců 80
Tržba na zaměstnance 1541000
Profit margin 6.23 %
Operating margin 5.54 %
Gross margin 100.00 %
EBIT margin 6.46 %
EBITDA margin 5.57 %
EPS - Zisk na akcii 0.26
EPS - Kvartální růst 12.96 %
EPS - Očekávaný růst příští rok 11.43 %
Return on assets 3.75 %
Return on equity 4.12 %
ROIC 3.06 %
ROCE 3.86 %
Dluhy/Equity 0.09
Čistý dluh/EBITDA -89.13
Current ratio 10.84
Quick Ratio 10.84
Volatilita 4.08
Beta 0.73
RSI 34.03
Cílová cena analytiků 33
Známka akcie (dle analytiků) N/A
Insider ownership 10.49 %
Institutional ownership 67.14 %
Počet akcií 50.09M
Procento shortovaných akcií 7.30 %
Short ratio 2.25 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie CARA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$19.886$13.469$0.911$0.086$3.803$3.177
Cost Of Goods Sold------
Gross Profit$19.886$13.469$0.911$0.086$3.803$3.177
Research And Development Expenses$113.82$75.531$48.524$49.253$21.221$15.068
SG&A Expenses$17.745$15.32$11.872$9.233$7.77$6.181
Other Operating Income Or Expenses------
Operating Expenses$131.565$90.851$60.396$58.486$28.991$21.249
Operating Income$-111.679$-77.382$-59.485$-58.4$-25.188$-18.072
Total Non-Operating Income/Expense$4.49$2.98$1.156$0.652$0.101$0.126
Pre-Tax Income$-107.189$-74.402$-58.329$-57.748$-25.087$-17.946
Income Taxes$-0.816$-0.389$-0.204$-0.468$-0.397$-0.201
Income After Taxes$-106.373$-74.013$-58.125$-57.28$-24.69$-17.745
Other Income------
Income From Continuous Operations$-106.373$-74.013$-58.125$-57.28$-24.69$-17.745
Income From Discontinued Operations------
Net Income$-106.373$-74.013$-58.125$-57.28$-24.69$-17.745
EBITDA$-112.261$-78.832$-59.572$-57.153$-24.367$-17.289
EBIT$-111.679$-77.382$-59.485$-58.4$-25.188$-18.072
Basic Shares Outstanding433631272521
Shares Outstanding433631272521
Basic EPS$-2.49$-2.06$-1.86$-2.10$-1.00$-0.85
EPS - Earnings Per Share$-2.49$-2.06$-1.86$-2.10$-1.00$-0.85
# 2020 2019 2018 2017 2016 2015
Current Ratio3.8624.15711.17545.327820.678415.6416
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin-561.5961-574.5192-6529.637-67906.98-662.3193-568.8386
EBIT Margin-561.5961-574.5192-6529.637-67906.98-662.3193-568.8386
EBITDA Margin-564.5228-585.2847-6539.188-66456.98-640.7311-544.1927
Pre-Tax Profit Margin-539.0175-552.3944-6402.744-67148.84-659.6635-564.8725
Net Profit Margin-534.914-549.5063-6380.351-66604.65-649.2243-558.5458
Asset Turnover0.08540.07060.00940.00130.03430.0568
Inventory Turnover Ratio------
Receiveable Turnover11.12828.47111.06670.09168.196115.885
Days Sales In Receivables32.799743.0878342.16253985.29144.533322.9777
ROE - Return On Equity-56.9714-55.3865-66.9797-112.9227-23.5044-34.3483
Return On Tangible Equity-56.9714-55.3865-66.9797-112.9226-23.5044-34.3483
ROA - Return On Assets-45.6617-38.7862-59.9202-89.7412-22.2639-31.7249
ROI - Return On Investment-56.9714-55.3865-66.9797-112.9226-23.5044-34.3483
Book Value Per Share3.99643.37892.65691.85833.85412.2657
Operating Cash Flow Per Share-1.93851.1358-0.0202-0.8645-0.0309-1.526
Free Cash Flow Per Share-1.93681.13430.0055-0.89-0.0297-1.5268

Porovnání s konkurencí: Akcie CARA

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CARA 51.31 N/A N/A % 11.43 % 4.12 % 2.68 6.23 %
Akcie ACOR N/A N/A -5.03 % 13.04 % -55.69 % 0.22 -65.11 %
Akcie DRRX N/A N/A -88.00 % 0.00 % -42.18 % 6.81 -1.93 %
Akcie CPIX 1,364.69 1.12 -6.85 % -300.00 % 0.06 % 0.85 -8.92 %
Akcie FLXN N/A N/A 26.81 % -16.00 % 331.20 % -27.49 -132.91 %
Akcie ACRX 0.00 N/A -30.34 % -30.00 % 82.88 % -2.18 -745.55 %
Akcie JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie REPH 0.00 N/A -20.17 % 0.00 % 669.75 % -4.05 -41.36 %
Akcie TRVN 0.00 N/A N/A % 125.00 % -40.89 % 1.83 -956.96 %

Nedávné obchody insiderů: Akcie CARA

Jméno Obchod Cena Objem
Christopher Posner
Director
Prodej
19 Nov 2020
$15.82 $31,640
Joana Goncalves
Chief Medical Officer
Prodej
23 Nov 2020
$15.31 $30,620
Derek T Chalmers
President and CEO
Prodej
10 Dec 2020
$15.29 $114,675
Derek T Chalmers
President and CEO
Prodej
16 Dec 2020
$14.95 $74,750
Joana Goncalves
Chief Medical Officer
Prodej
21 Dec 2020
$15.00 $30,000
Derek T Chalmers
President and CEO
Prodej
23 Dec 2020
$16.00 $80,000
Derek T Chalmers
President and CEO
Prodej
30 Dec 2020
$15.30 $92,993
Joana Goncalves
Chief Medical Officer
Prodej
30 Dec 2020
$15.30 $19,859
Frederique Ph.D. Menzaghi
Chief Scientific Off, SVP-R, and D
Prodej
30 Dec 2020
$15.30 $43,024
Scott Terrillion
Sec'y; Chief Compliance and G.C.
Prodej
30 Dec 2020
$15.30 $29,774
Joana Goncalves
Chief Medical Officer
Prodej
21 Jan 2021
$20.12 $40,240

Diskuze k akciím CARA